Skip to content

Kristian Reich, Chief Scientific Officer at MoonLake Immunotherapeutics, sold MLTX on Jun 17, 2026

Data as of Oct 16

▼ SELL$972K50,000 shares at $19.43Kristian Reich Chief Scientific OfficerMLTX MoonLake Immunotherapeutics
Watch MLTX
Traded
Jun 17, 2026
Disclosed
Jun 17, 2026
Filed
The same day

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Kristian Reich, Chief Scientific Officer at MoonLake Immunotherapeutics, sold MLTX on Jun 17, 2026TRADEDDISCLOSED
MLTXSimilar stocks (XLV — its sector index fund), rebased to MLTX's price on the disclosure day
MLTX since disclosure
−50.2%
after the sale
Similar stocks (XLV) since disclosure
+17.3%
XLV — its sector index fund

Change in closing price from Jun 17, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLKristian Reich Chief Scientific OfficerMLTX MoonLake Immunotherapeutics$935Kdisclosed Jun 17 · filed 1 day after the trade
  2. ▼ SELLKristian Reich Chief Scientific OfficerMLTX MoonLake Immunotherapeutics$945Kdisclosed Jun 17 · filed 2 days after the trade

See every trade on MLTX →